Sermorelin is a growth hormone-releasing hormone (GHRH) analogue that stimulates the pituitary gland to produce and release growth hormone naturally. Unlike direct growth hormone injections, sermorelin works through the body’s own regulatory feedback loop — producing physiologic growth hormone pulses rather than a fixed external dose.
What Sermorelin Does and How It Works
Growth hormone declines significantly with age. By the mid-30s, most adults produce about half the growth hormone they did in their 20s. By the 50s and 60s, output is a fraction of peak levels. This decline contributes to changes in body composition (more fat, less muscle), reduced recovery, disrupted sleep architecture, and reduced energy and stamina.
Want to talk it through with our team?
Book a free 15-minute video consult. Start for $247 — includes your first doctor visit. No membership.
Sermorelin stimulates the pituitary to produce growth hormone in pulses that mimic natural secretion patterns. This is clinically meaningful because it preserves feedback regulation — when growth hormone rises, the body downregulates production, preventing the supraphysiologic levels that come with direct GH injections. The result is a more physiologic response with a reduced risk of the side effects associated with exogenous growth hormone at high doses.
Who Is a Candidate for Sermorelin Therapy
Sermorelin is most appropriate for adults who have documented low or low-normal IGF-1 (insulin-like growth factor 1, the primary marker of growth hormone status) and symptoms consistent with growth hormone decline. Common indicators include:
- IGF-1 at or below the lower third of the age-adjusted reference range
- Persistent body composition changes — increased fat, reduced muscle — despite training and nutrition
- Poor sleep quality, particularly reduced deep (slow-wave) sleep
- Reduced exercise recovery and stamina compared to earlier years
- Generalized fatigue and reduced sense of vitality
Sermorelin is not appropriate for patients with active malignancy (growth hormone stimulates cell proliferation), untreated pituitary pathology, or proliferative diabetic retinopathy.
Expected Effects of Sermorelin Therapy
| Area | Typical Effect | Timeline |
|---|---|---|
| Sleep quality | Deeper sleep, improved slow-wave phase | 2–6 weeks |
| Energy and recovery | Improved stamina and post-exercise recovery | 4–8 weeks |
| Body composition | Reduced fat mass; increased lean muscle over time | 3–6 months |
| Skin and connective tissue | Improved collagen synthesis; skin quality changes | 3–6 months |
| IGF-1 levels | Rise toward mid-normal range (goal of therapy) | Monitored at 3 months |
Sermorelin vs. Direct Growth Hormone Injections
Direct growth hormone therapy (somatropin) requires FDA-approved medical indications and is significantly more expensive. Sermorelin is a peptide that stimulates endogenous production — it is not growth hormone itself. This distinction matters for both regulatory and physiologic reasons:
- Sermorelin preserves the pituitary’s regulatory function; direct GH injections can suppress it
- The pulsatile GH secretion from sermorelin more closely mimics natural patterns
- The side effect profile (fluid retention, joint swelling, insulin resistance) is less pronounced at therapeutic sermorelin doses than with direct GH
- Sermorelin is typically administered as a nightly subcutaneous injection timed to align with natural GH pulses during sleep
Sermorelin in Combination With Other Hormones
Sermorelin is often used as part of a broader hormone optimization program. Growth hormone, testosterone, and thyroid hormone interact significantly. Men on TRT who also have suppressed IGF-1 often see incomplete results from TRT alone until growth hormone status is addressed. The same applies to women on hormone therapy who have persistent body composition concerns despite optimized estrogen and testosterone.
Frequently Asked Questions
Is sermorelin a steroid?
No. Sermorelin is a peptide — a small chain of amino acids — not a steroid hormone. It stimulates pituitary function rather than providing a hormone directly. It does not affect androgen levels and has no anabolic steroid properties.
How is sermorelin administered?
Sermorelin is typically administered via small subcutaneous (under-skin) injection, most commonly in the evening to align with natural growth hormone pulses during sleep. Injection supplies are provided along with the prescription.
How long does sermorelin therapy last?
Treatment duration is individualized. Many patients use sermorelin for 6–12 months, then pause to assess the degree of residual IGF-1 improvement before determining whether continued treatment is warranted.
Can I get sermorelin through telehealth?
Yes. Telehealth providers can evaluate IGF-1 and growth hormone status through standard lab panels and prescribe sermorelin when clinically appropriate. Treatment and monitoring are managed remotely.
Evaluate Your Growth Hormone Status
MultiGen Wellness evaluates IGF-1 and growth hormone markers as part of comprehensive hormone panels. Sermorelin therapy is available for qualifying patients through telehealth. Learn about peptide therapy or book your consultation below.
How it works
From your first call to medication at your door.
- AFree 15-minute video consult. We go over your goals, answer your questions, and confirm we can treat you in your state.
- BStart for $247, which includes your first doctor visit.
- CLab work: free with insurance at Quest or any other lab. Book your Quest visit in your patient portal, or take our lab order form to any lab that takes your insurance.
- DDoctor visit: once results are back, meet by video with a dedicated hormone therapy specialist (PAs, NPs and doctors on staff) to review labs and plan medication or therapy.
- EMedication shipped to your door. We bill you for the medication and ship it to your house. See medication prices
What it costs
- No monthly fee, no membership, no commitment.
- $97 per visit, only when needed.
- Prescriptions need lab work and a video visit at least every 90 days.
- Most new patients are seen every 30 days at first.